Daily Caffeine Consumption is Associated with Decreased Incidence of Symptoms and Hemodynamic Changes During Pharmacologic Stress with Regadenoson.

Conclusion: Caffeine consumers receiving regadenoson stress MPI was very common, and use of regadenoson for MPI in caffeine consumers is safe and associated with lower incidence of certain symptoms compared to non-caffeine consumers. Specifically, caffeine intake was associated with less aminophylline use and chest pain. PMID: 31604901 [PubMed - as supplied by publisher]
Source: Journal of Nuclear Medicine Technology - Category: Nuclear Medicine Tags: J Nucl Med Technol Source Type: research